BridgeMD
New treatment option for Mild to Moderate Anxiety and Depression
Official title Digital Positive Affect Intervention Study
ClinicalTrials.gov ID: NCT06978257
What this study is testing
- What it's testing
- Anxiety and depression are highly prevalent mental health disorders that impose a significant burden on individuals and public health systems worldwide (GBD 2019 Mental Disorders Collaborators, 2022). Although many existing treatments focus on symptom reduction through targeting negative emotions, fewer interventions specifically enhance positive emotional experiences, despite growing evidence that low positive affect is a key feature of both anxiety and depression.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 64
You may be able to join if
- Adults aged between 21 and 64 years
- Proficient in written and spoken English
- Ability to provide informed consent
- Scores between 5 and 14 on the Generalized Anxiety Disorder-7 (GAD-7) scale OR
- Scores between 5 and 19 on the Patient Health Questionnaire-9 (PHQ-9) scale
You likely can't join if
- Failure to meet the above inclusion criteria
- Significant suicidal thoughts within the past two weeks, defined as self-reporting "more than half the days" or "nearly every day" on the PHQ-9 Item...
- Received psychiatric diagnoses of bipolar disorder, disorders of psychosis, severe clinical anxiety, or severe clinical depression.
- Severe clinical anxiety (scores of 15 to 21 on the GAD-7)
- Severe clinical depression (scores of 20-27 on the PHQ-9)
See the full eligibility criteria
- Adults aged between 21 and 64 years
- Proficient in written and spoken English
- Ability to provide informed consent
- Scores between 5 and 14 on the Generalized Anxiety Disorder-7 (GAD-7) scale OR
- Scores between 5 and 19 on the Patient Health Questionnaire-9 (PHQ-9) scale
- Scores below 6 on the Altman Self-Rating Mania (ASRM) scale
- Possess an active smartphone with a valid Singapore phone number
- Mainly based in Singapore, within the next 15 months
- Failure to meet the above inclusion criteria
- Significant suicidal thoughts within the past two weeks, defined as self-reporting "more than half the days" or "nearly every day" on the PHQ-9 Item 9.
- Received psychiatric diagnoses of bipolar disorder, disorders of psychosis, severe clinical anxiety, or severe clinical depression.
- Severe clinical anxiety (scores of 15 to 21 on the GAD-7)
- Severe clinical depression (scores of 20-27 on the PHQ-9)
The study team makes the final eligibility decision.
Where it's taking place
- Singapore, Singapore
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.